Literature DB >> 19624546

Quality of life in patients with epidermolysis bullosa.

S Tabolli1, F Sampogna, C Di Pietro, A Paradisi, C Uras, P Zotti, D Castiglia, G Zambruno, D Abeni.   

Abstract

BACKGROUND: Epidermolysis bullosa (EB) is a rare, inherited group of disorders characterized by blistering of the skin following friction or mechanical trauma. EB has a clinical and socioeconomic impact on patients and their families.
OBJECTIVES: To assess the quality of life (QoL) in patients with EB and to determine disease burden.
METHODS: The study was an observational, cross-sectional postal survey. One hundred and eighty-five patients were invited to participate. Different sets of questionnaires [Short Form-36 (SF-36), Skindex-29, General Health Questionnaire-12 (GHQ-12), EuroQol 5 dimensions] were sent to patients according to age. The perceived severity of the disease was evaluated by patients or by the mothers of the younger children with EB, using the Patient Global Assessment five-point scale. Carers received the Family Strain Questionnaire.
RESULTS: One hundred and twenty-five respondents were analysed. Patients with EB showed lower values in physical components of the SF-36, while the mental components were not significantly impaired. Among EB types, patients with junctional EB and severe generalized recessive dystrophic EB reported lower values and their GHQ-12 scores were significantly different from those of patients with EB simplex. There were no significant differences among EB types/subtypes for Skindex-29 values. Women had a worse QoL compared with men in all Skindex-29 and SF-36 scales (P < 0.05). GHQ-positive cases were more frequent among women (48%) compared with men (16%) (P = 0.003); GHQ-positive cases had a worse QoL compared with GHQ-negative patients. The patient QoL decreased and the family burden increased with increasing patient perceived disease severity and with increasing patient body surface involved. No differences were seen among EB types for the family burden.
CONCLUSIONS: In patients with EB mental components of SF-36 scores are similar to the normal population. The perceived disease severity and skin area involved are relevant for QoL in all EB types/subtypes. EB imposes a heavy burden on the caregiver and the family. Psychological support and close monitoring of QoL may help patients with EB and their carers.

Entities:  

Mesh:

Year:  2009        PMID: 19624546     DOI: 10.1111/j.1365-2133.2009.09306.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  34 in total

1.  Understanding the outcomes of a home nursing programme for patients with epidermolysis bullosa: an Australian perspective.

Authors:  Louise J Stevens; Sue McKenna; Jennifer Marty; Allison J Cowin; Zlatko Kopecki
Journal:  Int Wound J       Date:  2014-12-03       Impact factor: 3.315

Review 2.  Psychosocial impact of inherited and autoimmune blistering diseases.

Authors:  Swaranjali V Jain; Dedee F Murrell
Journal:  Int J Womens Dermatol       Date:  2018-01-08

3.  Quality of life in dermatomyositis.

Authors:  Renato Goreshi; Monika Chock; Kristen Foering; Rui Feng; Joyce Okawa; Matt Rose; David Fiorentino; Victoria Werth
Journal:  J Am Acad Dermatol       Date:  2011-07-01       Impact factor: 11.527

4.  A consensus approach to wound care in epidermolysis bullosa.

Authors:  Elena Pope; Irene Lara-Corrales; Jemima Mellerio; Anna Martinez; Gregory Schultz; Robert Burrell; Laurie Goodman; Patricia Coutts; John Wagner; Upton Allen; Gary Sibbald
Journal:  J Am Acad Dermatol       Date:  2012-03-02       Impact factor: 11.527

5.  Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa.

Authors:  Francesco Margari; Paola A Lecce; Wanda Santamato; Patrizia Ventura; Nicola Sportelli; Giuseppina Annicchiarico; Ernesto Bonifazi
Journal:  J Clin Psychol Med Settings       Date:  2010-12

Review 6.  Quality of life in patients with bullous dermatoses.

Authors:  Deshan F Sebaratnam; James R McMillan; Victoria P Werth; Dédée F Murrell
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

7.  Adopting a Sustainable Community of Practice Model when Developing a Service to Support Patients with Epidermolysis Bullosa (EB): A Stakeholder-Centered Approach.

Authors:  Rosemary Joan Gowran; Avril Kennan; Siobhán Marshall; Irene Mulcahy; Sile Ní Mhaille; Sarah Beasley; Mark Devlin
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

8.  Quality of life in adults with facial port-wine stains.

Authors:  Solveig L Hagen; Katherine R Grey; Dorota Z Korta; Kristen M Kelly
Journal:  J Am Acad Dermatol       Date:  2016-12-09       Impact factor: 11.527

9.  The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology.

Authors:  Anette Bygum; Emel Aygören-Pürsün; Teresa Caballero; Kathleen Beusterien; Shadi Gholizadeh; Patience Musingarimi; Suzanne Wait; Henrik Boysen
Journal:  BMC Dermatol       Date:  2012-04-26

10.  The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases.

Authors:  Brigitta E Miyamoto; Emil D Kakkis
Journal:  Orphanet J Rare Dis       Date:  2011-07-06       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.